Leukoencephalopathy

Results: 60



#Item
21HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NULOJIX safely and effectively. See full prescribing information for NULOJIX. NULOJIX (belatacept) for injection, fo

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NULOJIX safely and effectively. See full prescribing information for NULOJIX. NULOJIX (belatacept) for injection, fo

Add to Reading List

Source URL: packageinserts.bms.com

Language: English - Date: 2014-12-04 10:12:40
22Minutes of the Session on Development of a Program for Surveillance of PML at the American Neurological Association Meeting Place: Essex Room, Marriott Hotel, Baltimore MD Date: October 13, 2009 Panel: Eugene Major PhD,

Minutes of the Session on Development of a Program for Surveillance of PML at the American Neurological Association Meeting Place: Essex Room, Marriott Hotel, Baltimore MD Date: October 13, 2009 Panel: Eugene Major PhD,

Add to Reading List

Source URL: patients.aan.com

Language: English - Date: 2009-11-10 12:34:54
23•	 Reversible Posterior Leukoencephalopathy Syndrome (RPLS) has been observed and can be fatal. Permanently discontinue VOTRIENT in patients developing RPLS. (5.9) •	 Hypertension including hypertensive crisis has be

• Reversible Posterior Leukoencephalopathy Syndrome (RPLS) has been observed and can be fatal. Permanently discontinue VOTRIENT in patients developing RPLS. (5.9) • Hypertension including hypertensive crisis has be

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-11-19 13:09:31
24Microsoft PowerPoint - A Case Study Using the BRAT Framework and Quantitative Methods for Benefit-Risk Assessment - Final 20131

Microsoft PowerPoint - A Case Study Using the BRAT Framework and Quantitative Methods for Benefit-Risk Assessment - Final 20131

Add to Reading List

Source URL: www.amstat.org

Language: English - Date: 2013-11-12 00:22:34
25What’s “hot” about thermogenic agents

What’s “hot” about thermogenic agents

Add to Reading List

Source URL: dpic.org

Language: English - Date: 2014-11-10 15:46:29
26Neuroradiological, clinical and genetic characterization of new forms of hereditary leukoencephalopathies Principal Investigator: Dr. Donatella Tampieri, MD, FRCPC, Department of Neuroradiology, Montreal Neurological Ins

Neuroradiological, clinical and genetic characterization of new forms of hereditary leukoencephalopathies Principal Investigator: Dr. Donatella Tampieri, MD, FRCPC, Department of Neuroradiology, Montreal Neurological Ins

Add to Reading List

Source URL: www.car.ca

Language: English - Date: 2013-06-07 13:56:11
27Reversible leukoencephalopathy associated with cerebral amyloid angiopathy U. Oh, R. Gupta, J. W. Krakauer, A. G. Khandji, S. S. Chin and M. S.V. Elkind Neurology 2004;62;[removed]This information is current as of Septemb

Reversible leukoencephalopathy associated with cerebral amyloid angiopathy U. Oh, R. Gupta, J. W. Krakauer, A. G. Khandji, S. S. Chin and M. S.V. Elkind Neurology 2004;62;[removed]This information is current as of Septemb

Add to Reading List

Source URL: blam-lab.org

Language: English - Date: 2012-07-26 22:31:06
28Initial REMS Approval: June[removed]BLA[removed]NULOJIX (belatacept) Selective T-cell costimulation blocker Bristol-Myers Squibb (BMS) Company

Initial REMS Approval: June[removed]BLA[removed]NULOJIX (belatacept) Selective T-cell costimulation blocker Bristol-Myers Squibb (BMS) Company

Add to Reading List

Source URL: www.fda.gov

Language: English
29RAPTIVA® [efalizumab] For injection, subcutaneous WARNING: RISK OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) •	 RAPTIVA increases the risk for PML, a rapidly progressive viral infection of

RAPTIVA® [efalizumab] For injection, subcutaneous WARNING: RISK OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) • RAPTIVA increases the risk for PML, a rapidly progressive viral infection of

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:51:38
30Possible mechanisms of the disease

Possible mechanisms of the disease

Add to Reading List

Source URL: www.fda.gov

Language: English